[go: up one dir, main page]

TW200635580A - Methods of treatment and prevention - Google Patents

Methods of treatment and prevention

Info

Publication number
TW200635580A
TW200635580A TW094141796A TW94141796A TW200635580A TW 200635580 A TW200635580 A TW 200635580A TW 094141796 A TW094141796 A TW 094141796A TW 94141796 A TW94141796 A TW 94141796A TW 200635580 A TW200635580 A TW 200635580A
Authority
TW
Taiwan
Prior art keywords
prevention
treatment
methods
xylpoyranoside
benzopyran
Prior art date
Application number
TW094141796A
Other languages
Chinese (zh)
Inventor
Jeffrey W Dubb
Linda S Henderson
Shunichiro S Okada
Vincent Peyrou
Robert E Samuels
Sunita Sheth
Patricia A Spera
John R Toomery
Douglas E Wilson
Original Assignee
Glaxo Group Ltd
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36565378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200635580(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd, Fournier Lab Sa filed Critical Glaxo Group Ltd
Publication of TW200635580A publication Critical patent/TW200635580A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed are methods for the treatment and/or prevention of thromboembolic disorders, comprising administering 4-methyl-2-oxo-2H-1-benzopyran-7-yl-5-thio-β-D-xylpoyranoside in effective amounts.
TW094141796A 2004-12-01 2005-11-29 Methods of treatment and prevention TW200635580A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63215304P 2004-12-01 2004-12-01
US69172805P 2005-06-17 2005-06-17
US72169105P 2005-09-29 2005-09-29
US72471005P 2005-10-07 2005-10-07

Publications (1)

Publication Number Publication Date
TW200635580A true TW200635580A (en) 2006-10-16

Family

ID=36565378

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094141796A TW200635580A (en) 2004-12-01 2005-11-29 Methods of treatment and prevention

Country Status (5)

Country Link
AR (1) AR053789A1 (en)
PE (1) PE20061246A1 (en)
TW (1) TW200635580A (en)
UY (1) UY29237A1 (en)
WO (1) WO2006060647A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801055B1 (en) * 1999-11-17 2002-02-08 Fournier Ind & Sante BETA-D-5-THIOXYLOSE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE

Also Published As

Publication number Publication date
UY29237A1 (en) 2006-05-31
WO2006060647A1 (en) 2006-06-08
AR053789A1 (en) 2007-05-23
PE20061246A1 (en) 2006-11-08

Similar Documents

Publication Publication Date Title
TW200637522A (en) Skin treatment articles and methods
GB2463833A (en) Methods and compositions for the treatment of neurological disorders
TW200507830A (en) Bronchodilating β -agonist compositions and methods
WO2003101397A3 (en) Tetravalent dengue vaccines
TW200510416A (en) P38 inhibitors and methods of use thereof
MXPA06014510A (en) Compositions and methods for treating inflammatory disorders.
WO2004078116A3 (en) P38 inhibitors and methods of use thereof
WO2006024018A3 (en) Compositions for treating nociceptive pain
WO2004006858A3 (en) Compounds, compositions, and methods employing same
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
WO2007011962A3 (en) Treatment of cancer
EP2023926A4 (en) Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
PL1902141T3 (en) Adamts13-comprising compositions having thrombolytic activity
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
MX2008015775A (en) Compounds and compositions for treatment of cancer.
WO2006055871A3 (en) Treatment for multiple sclerosis
WO2006074265A3 (en) Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
MY135829A (en) Analeptic and drug combinations
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
WO2007047608A3 (en) Fibrin targeted therapeutics
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
WO2005013911A3 (en) Protective and therapeutic uses for tocotrienols
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2006122123A3 (en) Methods of alleviating disorders and their associated pain